Isolates are typically the CBD oil product of choice for those who get drug tested or are sensitive to other cannabinoids such as THC. Products labeled as isolates will generally be highlighted as being 99+% “pure CBD.” Usually, these products will have nothing but CBD in them because the CBD has literally been isolated from everything else. You can find pre-made isolate oils that typically consist of a carrier oil, such as MCT oil, infused with the crystalline isolate powder. You can also find the “raw” CBD crystalline powder or slabs (a form of concentrate) on its own.
Because of recent legislation legalizing marijuana, CBD product sales have grown. People are more open to the medical benefits of the drug, especially now that CBD can be separated from THC. With popularity and interest on the rise, manufacturers have expanded their product offerings. Products typically come in two types: nutritional or medicinal products and beauty products.
Hi, Jim, and thanks for writing! We have heard many great testimonials about how our CBD has helped folks with their anxiety. One tip we recommend, is to take 30 minutes before bed, while reducing screen time as much as possible during that time. Also, if users anticipate a stressful event (meeting, interview, etc.), we recommend taking it 30 minutes to an hour before the event. Please let us know what you think, and please feel free to leave us a review with your feedback, here: https://floydsofleadville.com/product/tincture-600mg/#tab-reviews Thanks!
Disclaimer: The information provided on this site is intended for your general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. You should not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Your use of this website indicates your agreement to this websites published terms of use and all site policies. Please see our Medical Disclaimer for more information.
Zuardi, A. W., Crippa, J. A., Hallak, J. E., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., … & Guimarães, F. S. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Abstract]. Current Pharmaceutical Design, 18(32), 5,131–5,140. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22716160
×